Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
CALL
Aptiv
APTV
$10.3B
| $14M | 0.01% |
166,800
+19,600
| +13% | +$1.79M |
|
1052
Ingredion
INGR
$6.58B
| $13.9M | 0.01% |
132,850
+49,355
| +59% | +$5.04M |
|
1053
PUT
Acadia Pharmaceuticals
ACAD
$5.03B
| $13.9M | 0.01% |
670,500
+516,600
| +336% | +$8.13M |
|
1054
Rogers Communications
RCI
$18.6B
| $13.9M | 0.01% |
270,632
+66,343
| +32% | +$3.39M |
|
|
KSU
1055
CALL
DELISTED
Kansas City Southern
KSU
| $13.9M | 0.01% |
122,800
+87,000
| +243% | +$9.91M |
|
|
SEP
1056
DELISTED
Spectra Engy Parters Lp
SEP
| $13.9M | 0.01% |
389,142
+52,350
| +16% | +$1.94M |
|
1057
Nice
NICE
$5.97B
| $13.9M | 0.01% |
121,381
-9,037
| -7% | -$1.01M |
|
1058
CALL
Kohl's
KSS
$2.19B
| $13.9M | 0.01% |
186,300
-4,500
| -2% | -$340K |
|
1059
Terex
TEX
$7.74B
| $13.9M | 0.01% |
347,901
+143,224
| +70% | +$5.82M |
|
1060
CALL
Elevance Health
ELV
$85.5B
| $13.9M | 0.01% |
50,600
-40,500
| -44% | -$10.5M |
|
1061
CALL
ServiceNow
NOW
$129B
| $13.9M | 0.01% |
354,000
+215,500
| +156% | +$8.15M |
|
1062
CALL
Edwards Lifesciences
EW
$51.7B
| $13.8M | 0.01% |
238,200
+170,700
| +253% | +$8.35M |
|
1063
PUT
ConocoPhillips
COP
$141B
| $13.8M | 0.01% |
178,300
+27,100
| +18% | +$1.95M |
|
1064
Avnet
AVT
$7.92B
| $13.8M | 0.01% |
308,172
+267,276
| +654% | +$12.3M |
|
1065
Fluor
FLR
$7.96B
| $13.8M | 0.01% |
237,410
+64,158
| +37% | +$3.5M |
|
1066
CALL
Philip Morris
PM
$295B
| $13.8M | 0.01% |
169,100
-24,700
| -13% | -$2.03M |
|
1067
PUT
Raymond James Financial
RJF
$34B
| $13.8M | 0.01% |
224,400
+218,550
| +3,736% | +$13.5M |
|
1068
CALL
Kroger
KR
$34.8B
| $13.8M | 0.01% |
472,800
-18,300
| -4% | -$545K |
|
1069
CALL
Danaher
DHR
$144B
| $13.7M | 0.01% |
142,015
-49,632
| -26% | -$4.52M |
|
|
NBL
1070
DELISTED
Noble Energy, Inc.
NBL
| $13.7M | 0.01% |
438,313
+38,984
| +10% | +$1.25M |
|
1071
PUT
United Parcel Service
UPS
$88.9B
| $13.7M | 0.01% |
117,000
-97,900
| -46% | -$11.5M |
|
1072
Logitech
LOGI
$15.2B
| $13.6M | 0.01% |
304,602
-92,204
| -23% | -$4.28M |
|
1073
PUT
CarMax
KMX
$8.26B
| $13.6M | 0.01% |
181,600
+157,900
| +666% | +$12M |
|
1074
PUT
Hershey
HSY
$36.6B
| $13.6M | 0.01% |
132,900
+44,300
| +50% | +$4.38M |
|
|
ESRX
1075
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $13.5M | 0.01% |
142,600
-67,600
| -32% | -$5.76M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.